AAPL 258.2 1.1478% MSFT 439.33 0.9374% NVDA 140.22 0.3938% GOOGL 196.11 0.7604% GOOG 197.57 0.8062% AMZN 229.05 1.7729% META 607.75 1.317% AVGO 239.68 3.1547% TSLA 462.28 7.3572% TSM 206.33 -0.4967% LLY 795.67 -0.0766% V 320.65 1.0813% JPM 242.31 1.6444% UNH 506.1 -0.0474% NVO 87.37 -1.5105% WMT 92.68 2.5789% LVMUY 132.15 0.1516% XOM 106.4 0.0941% LVMHF 655.0 -0.2543% MA 535.71 1.2761%
Company Overview: Premium Nickel Resources Ltd. (TSXV: PNRL) a Canadian company, focuses exclusively on the exploration and development of high-grade nickel, copper, and cobalt resources. INVO Bioscience, Inc. (NASDAQ: INVO) is a pioneering healthcare services company specializing in fertility care. Dedicated to broadening access to assisted reproductive technology (ART) globally, the company aims to make fertility treatments more accessible and inclusive. This Report covers the Price Action, Technical Indicators Analysis along with the Stop Loss Levels, Target Prices, and Recommendations on these two stocks.
Global Markets Wrap-Up
On June 27, 2024, the S&P 500 index settled at 5482.87 with a week till date gain of 0.18%; moreover, the tech-heavy NASDAQ composite increased by ~0.96% on a WTD basis and settled at 17858.68 while, the Russell 2000 settled at 2038.34, reflecting a gain of ~0.81% on WTD basis.
Considering the Canadian market, the benchmark S&P/TSX Venture Composite Index (TSX: ^JX) started the week on a negative note and continued the momentum. On June 27, 2024, the index closed at 570.55 with an overall week-to-date (WTD) loss of 0.03%. Energy, Basic Materials, Financials, Consumer Cyclicals, Industrials, and Technology were the leading sectors, While Real Estate and Healthcare were the laggards on Thursday.
Xxxxxx Xxxxxx Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx Xxxxxx Xxxxxx Xxxxxx & Xxxxxx
Xxxxxx Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Xxxxxx
Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx Xxxxxx .
Enter your details below and our team will help you to decide if this product is best for you.
Kalkine Equities LLC provides general information about companies and their securities. The information contained in the reports, including any recommendations regarding the value of or transactions in any securities, does not take into account any of your investment objectives, financial situation or needs. Kalkine Equities LLC is not registered as an investment adviser in the U.S. with either the federal or state government. Before you make a decision about whether to invest in any securities, you should take into account your own objectives, financial situation and needs and seek independent financial advice. All information in our reports represents our views as at the date of publication and may change without notice.
Kalkine Media LLC, an affiliate of Kalkine Equities LLC, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.
US 
AU
UK
CA
NZ
Please wait processing your request...